UnitedHealth Group (NYSE:UNH) Stock Price Down 5.5% – What’s Next?

UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s stock price was down 5.5% during mid-day trading on Thursday. The stock traded as low as $324.67 and last traded at $330.58. 19,789,163 shares changed hands during trading, an increase of 173% from the average daily volume of 7,251,102 shares. The stock had previously closed at $349.91.

Trending Headlines about UnitedHealth Group

Investors following UNH have been watching these headlines:

Analyst Ratings Changes

A number of research firms have recently weighed in on UNH. New Street Research set a $402.00 price objective on shares of UnitedHealth Group in a research report on Friday, October 9th. Stephens set a $500.00 target price on shares of UnitedHealth Group in a report on Friday, October 16th. HC Wainwright set a $500.00 price objective on shares of UnitedHealth Group in a research note on Friday, October 16th. Barclays dropped their price objective on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a report on Wednesday, October 14th. Finally, Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $463.93.

View Our Latest Research Report on UNH

UnitedHealth Group Trading Down 5.5%

The business’s 50 day moving average is $390.56 and its two-hundred day moving average is $367.04. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $296.21 billion, a P/E ratio of 18.88, a PEG ratio of 1.41 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the business earned $2.59 EPS. The company’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.8%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several hedge funds have recently made changes to their positions in the stock. Fi3 FINANCIAL ADVISORS LLC acquired a new stake in UnitedHealth Group during the third quarter worth $769,000. Heartland Bank & Trust Co raised its position in UnitedHealth Group by 4.2% in the 3rd quarter. Heartland Bank & Trust Co now owns 3,749 shares of the healthcare conglomerate’s stock valued at $1,376,000 after purchasing an additional 152 shares during the last quarter. Kensington Investment Counsel LLC lifted its position in UnitedHealth Group by 1.8% during the 3rd quarter. Kensington Investment Counsel LLC now owns 8,162 shares of the healthcare conglomerate’s stock worth $2,996,000 after buying an additional 143 shares in the last quarter. Robinhood Markets Inc. bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $114,000. Finally, Innovator Capital Management LLC bought a new position in UnitedHealth Group in the third quarter valued at about $18,310,000. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Read More

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.